Resources/MoCRA
MoCRA: what US cosmetic brands should know
Published May 1, 2026
Disclaimer: The information provided in this guide is for educational and regulatory context purposes only and does not constitute formal legal advice. Compliance requirements can vary based on formulation, regional authority updates, and specific product claims. Consult a certified regulatory affairs professional or specialized legal counsel for official filings.
The Modernization of Cosmetics Regulation Act (MoCRA) expanded FDA expectations for cosmetics sold in the United States: more systematic facility registration, product listing, serious adverse event handling and recordkeeping, and pathways for substance review—all alongside longstanding ingredient prohibitions, restrictions, and truthful labeling rules.
Key takeaways
- "We buy turnkey bulk" isn't a compliance strategy on its own — contracts and QA maps need to name which entity registers, lists, maintains safety substantiation, and files adverse events.
- Product listing gives FDA structured information — it isn't formula approval, and doesn't substitute for a defensible safety story or compliant ingredient use.
- National MoCRA compliance doesn't erase state-level rules — California and other states maintain their own disclosure and warning requirements on top of it.
Who does the work when the brand outsources?
Contract manufacturers, brand holders, and importers often split duties. MoCRA asks you to be explicit about which entity registers, lists, maintains safety substantiation, and files adverse events. “We buy turnkey bulk” is not a compliance strategy unless your contracts and QA maps say who owns each FDA-facing obligation.
Product listing ≠ formula approval
Listing provides structured information to FDA; it does not mean FDA approved the formula. You still need a defensible safety story, compliant ingredient use, and accurate claims and labels. Listing and adverse-event infrastructure should connect to your change-control process when ingredients or suppliers change.
State overlays still exist
California and other states maintain additional disclosure or warning concepts (for example substances under spotlight programs). National MoCRA compliance does not automatically erase state labeling questions—your pack copy and supply-chain disclosures need a 50-state sweep where you distribute.
Operational checklist (starting point)
- Map legal entity responsible for facility registration and renewal timeline.
- Align SKU master data to FDA product listing fields; avoid “legacy” codes that never sync to RA.
- Train customer service and medical teams on serious adverse event criteria and escalation.
- Tie formula revisions to label panels, INCI order, and any fragrance disclosures (EU allergen guide) for exports.
Deep dives: facility registration & product listing, serious adverse event reporting, GMP status.
Use The Molecule Lab workspace for US-restricted lists, state snapshots, fragrance allergens, and formula-scale checks alongside other markets—start at sign in.